跳至主要内容
临床试验/NL-OMON35572
NL-OMON35572已完成不适用

Effects of two different isoflavone supplement preparations on gene-expression in postmenopausal women - ISO II study

Wageningen Universiteit0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 50-70 year
  • postmenopausal

排除标准

  • - current use of contraceptives containing hormones
  • - current use of hormone replacement therapy
  • - regular soy product use (more than once a week)
  • - regular isoflavone supplement use (more than once a week)
  • - current use of medication containing sexhormones or sexhormone-triggering compounds
  • - current use of anti-inflammatory medicines
  • - use of antibiotics in the past 3 months
  • - severe heart disease
  • - diabetes
  • - thyroid disorders --> use of medicines for thyroid disorders
  • - removed thyroid gland
  • - complete ovarectomy
  • - prior diagnosis of cancer in medical history
  • - alcohol and drug abuse
  • - current smoker
  • - BMI >35 kg/m2
  • - allergy to soy (products)

研究者

相似试验